Author

Ewan K.A. Millar

UNSW SydneyORCID 0000-0002-9778-3253Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

Antonia L. CadelliD· 2 shared David R. CroucheriD· 2 shared Elgene LimiD· 2 shared Adelaide I.J. YoungiD· 1 shared Alexander SwarbrickiD· 1 shared Benjamin L. ParkeriD· 1 shared Carla L. AlvesiD· 1 shared Catherine Elizabeth CaldoniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Antonia L. CadellORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Stromal cell subsets modulate T-cell infiltration in early breast cancer

Julia Chen, Hanyun Zhang, Travis Ruan, Sunny Z. Wu, Iveta Šlapetová, Ewan K.A. Millar, Peter Graham, Jodi Lynch, Lois H Browne, Elgene Lim, Alexander Swarbrick

The paper identifies stromal cell subsets in breast cancer that influence T-cell infiltration and patient outcomes through spatial and clinical analysis.

Cancer Research Communications · Jun 12, 2026Peer-reviewedCancer Biology

A selective inhibitor of oncogenic JNK signalling perturbs metastatic outgrowth of triple-negative breast cancer through metabolic blockade

Sharissa L. Latham, Yolande E. I. O’Donnell, Oscar Girgis-Cook, Misaki S. Clearwater, Nicole S. Bryce, Ellie T. Y. Mok, Sophie A Lynn, Jing Ni, Stephanie Alfred, King Ho Leong, Lake‐Ee Quek, Kendelle Joan Murphy, Chiara Pantarelli, Iliya Dragutinovic, Marjan Mojtabavi Naeini, , David R. Croucher

The paper identifies a selective JNK inhibitor that blocks metastasis in triple-negative breast cancer by targeting metabolic pathways.

bioRxiv · Apr 16, 2025 · PreprintCancer Biology

JNK pathway suppression drives resistance to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer

Sarah Alexandrou, Christine S Lee, Kristine J. Fernandez, Celine E Wiharja, Leila Eshraghi, John Reeves, Daniel A. Reed, Neil Portman, Zoe Phan, Heloisa Helena Milioli, Iva Nikolić, Antonia L. Cadell, David R. Croucher, Kaylene J. Simpson, Elgene Lim, , Catherine Elizabeth Caldon

This study identifies JNK pathway suppression as a driver of resistance to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer, with implications for patient stratification.

bioRxiv · Jan 8, 2025 · PreprintCancer Biology